CIK: 0001704132
Total reported value
$237.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BHVN | Biohaven Ltd. | Stock-Other | 14.53% | — | +0.55% | |
| 2 | INSM | Insmed INC | Stock-Healthcare | 11.91% | — | +9.81% | |
| 3 | MYOKEUR | Myokardia INC | Stock-Other | 10.91% | — | -4.82% | |
| 4 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 9.50% | — | +30.04% | |
| 5 | IMMU | Immunomedics INC | Stock-Other | 7.90% | — | -2.13% | |
| 6 | ASND | Ascendis Pharma A/S | Stock-Other | 7.06% | — | — | |
| 7 | REPL | Replimune Group INC | Stock-Other | 5.64% | — | — | |
| 8 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 4.94% | — | -42.60% | |
| 9 | ✓ | Optinose INC | Stock-Other | 4.86% | — | +17.14% | |
| 10 | ORTXUSD | Orchard Therapeutics PLC | Stock-Other | 4.83% | — | — | |
| 11 | AERIEUR | Aerie Pharmaceuticals INC | Stock-Other | 4.34% | — | — | |
| 12 | ABUS | Arbutus Biopharma CORP | Stock-Other | 2.78% | — | -40.89% | |
| 13 | EIDXGBP | Eidos Therapeutics INC | Stock-Other | 2.73% | — | -17.76% | |
| 14 | ACRS | Aclaris Therapeutics INC | Stock-Other | 2.54% | — | +41.28% | |
| 15 | PTLAEUR | Portola Pharmaceuticals INC | Stock-Other | 2.24% | — | — | |
| 16 | SIBN | Si-bone INC | Stock-Other | 1.97% | — | — | |
| 17 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 0.82% | — | -32.34% | |
| 18 | CYTK | Cytokinetics INC | Stock-Healthcare | 0.51% | +1.31% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BHVN | Biohaven Ltd. | +4.1% | +0.55% | Add |
| 2 | CBAYUSD | Cymabay Therapeutics INC | +2.2% | +30.04% | Add |
| 3 | ASND | Ascendis Pharma A/S | +1.4% | — | Unchanged |
| 4 | EIDXGBP | Eidos Therapeutics INC | +1% | -17.76% | Trim |
| 5 | KNSA | Kiniksa Pharmaceuticals International, plc | 0% | -32.34% | Trim |
| 6 | ACRS | Aclaris Therapeutics INC | 0% | +41.28% | Add |
| 7 | MYOKEUR | Myokardia INC | 0% | -4.82% | Trim |
| 8 | INSM | Insmed INC | 0% | +9.81% | Add |
| 9 | IMMU | Immunomedics INC | -0.5% | -2.13% | Trim |
| 10 | REPL | Replimune Group INC | -0.9% | — | Unchanged |
| 11 | ✓ | Optinose INC | -1.1% | +17.14% | Add |
| 12 | RYTM | Rhythm Pharmaceuticals INC | -1.7% | -42.60% | Trim |
| 13 | ABUS | Arbutus Biopharma CORP | -5.5% | -40.89% | Trim |
| 14 | ALDR1EUR | Alder Biopharmaceuticals INC | — | EXIT | Sold out |
| 15 | ORTXUSD | Orchard Therapeutics PLC | — | NEW | New buy |
| 16 | AERIEUR | Aerie Pharmaceuticals INC | — | NEW | New buy |
| 17 | OMER | Omeros CORP | — | EXIT | Sold out |
| 18 | XENE | Xenon Pharmaceuticals INC | — | EXIT | Sold out |
| 19 | PTLAEUR | Portola Pharmaceuticals INC | — | NEW | New buy |
| 20 | SIBN | Si-bone INC | — | NEW | New buy |
| 21 | RCUS | Arcus Biosciences INC | — | EXIT | Sold out |
| 22 | 2JQ | Gritstone Bio INC | — | EXIT | Sold out |
| 23 | CRNX | Crinetics Pharmaceuticals In | — | EXIT | Sold out |
| 24 | CYTK | Cytokinetics INC | — | NEW | New buy |
| 25 | QURE | uniQure N.V. | — | EXIT | Sold out |
| 26 | VRNA | Verona Pharma PLC - Adr | — | EXIT | Sold out |